Skip to content

US · ASTH · MEDICAL - CARE FACILITIES

Astrana Health, Inc. (ASTH) intrinsic value and stock valuation

$28.90as of 2026-11-21 · Mkt cap 1.78B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Astrana Health, Inc. DCF and intrinsic value

InvestorsCraft values ASTH with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from ASTH’s statements →

Astrana Health, Inc. Graham Number

Graham Number: $10.83d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Alhambra, CA 91801 astranahealth.com

How the business is doing

Fiscal 2016–2025, USD

Revenue
$3.18B+53.8% 5y CAGRd
20162025
Net income
$22.5M
20162025
Free cash flow
$104.5M+18.4% 5y CAGRd
20162025
Total equity
$558.3M+4.6% 5y CAGRd
20162025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2016–2025, USD
20252024202320222021
Revenue$3.18B$2.03B$1.39B$1.14B$773.9M
Operating income$78.5M$89.4M$84.6M$104.3M$98.2M
Net income$22.5M$43.2M$60.7M$45.2M$68.9M
EPSd$455.5K$894.9K$1.29M$990.6K$1.52M
Operating cash flow$114.6M$52.2M$68.2M$82.1M$70.3M
Capital expenditure-$-10.11M-$-8.03M-$-28.53M-$-22.94M-$-19.22M
Free cash flow$104.5M$44.2M$39.7M$59.2M$51.1M
Total assets$2.22B$1.35B$933.4M$966.2M$867.4M
Total debt$1.08B$471.8M$321M$229.4M$201M
Net debt$648.7M$183.4M$27.2M-$-58.66M-$-32.11M
Total equity$558.3M$514.2M$410.8M$558.6M$510.6M
Cash and short-term investments$429.5M$290.8M$296.3M$293.6M$286.5M
Income statement
20252024202320222021
Revenue$3.18B$2.03B$1.39B$1.14B$773.9M
Cost of revenue$2.89B$1.76B$1.17B$944.7M$596.1M
Gross profit$295.8M$271.4M$215M$199.5M$177.8M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$217.3M$154.1M$112.6M$77.7M$62.1M
Other expenses$0.00$27.9M$17.8M$17.5M$17.5M
Operating expenses$217.3M$182M$130.3M$95.2M$79.6M
Cost and expenses$3.1B$1.95B$1.3B$1.04B$675.7M
Interest income$12.2M$14.5M$14.2M$1.98M$1.57M
Interest expense$49.9M$33.1M$16.1M$7.92M$5.39M
Depreciation and amortization$45.8M$27.9M$17.8M$17.5M$17.5M
Ebitda$135.3M$141.8M$123.7M$112.1M$100.7M
Operating income$78.5M$89.4M$84.6M$104.3M$98.2M
Total other income/expenses, net-$-38.92M-$-8.53M$5.22M-$-17.65M-$-20.43M
Income before tax$39.6M$80.8M$89.8M$86.6M$77.8M
Income tax expense$15.5M$30.9M$32M$40.9M$31.7M
Net income$22.5M$43.2M$60.7M$45.2M$68.9M
Weighted average shares outstanding$49.1M$47.7M$46.7M$45M$43.8M
Weighted average diluted shares outstanding$49.4M$48.2M$47.1M$45.6M$45.4M
Balance sheet
20252024202320222021
Cash and short-term investments$429.5M$290.8M$296.3M$293.6M$286.5M
Net receivables$407.6M$324.8M$147.8M$119.7M$99.3M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$863.3M$638.5M$461.5M$428.1M$404.5M
Property, plant and equipment, net$94.4M$46.9M$44.6M$129M$68.6M
Goodwill and intangible assets$1.13B$537.4M$350.5M$345.9M$329.2M
Long-term investments$25.6M$48.2M$32.2M$42.7M$42.6M
Total non-current assets$1.36B$716.4M$471.9M$538.1M$462.9M
Total assets$2.22B$1.35B$933.4M$966.2M$867.4M
Accounts payable$44.8M$15.2M$9.07M$10.5M$5.51M
Short-term debt$55.7M$15.3M$24.8M$4.79M$3.9M
Deferred revenue$2.66M$1.61M$740K$530K$16.8M
Total current liabilities$615.3M$365.6M$218.7M$148.6M$114.7M
Long-term debt$1.02B$456.6M$296.3M$224.6M$197.1M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$1.05B$475.1M$303.9M$259.1M$242M
Capital lease obligations$39.4M$37.2M$42.6M$25.4M$17.3M
Total liabilities$1.66B$840.7M$522.6M$407.7M$356.7M
Common stock$50K$50K$50K$50K$40K
Retained earnings$308.4M$286.3M$243.1M$182.4M$137.3M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$558.3M$514.2M$410.8M$558.6M$510.6M
Total investments$25.6M$50.6M$34.7M$48.3M$96M
Total debt$1.08B$471.8M$321M$229.4M$201M
Net debt$648.7M$183.4M$27.2M-$-58.66M-$-32.11M
Cash flow statement
20252024202320222021
Net income$24.1M$49.9M$57.9M$45.7M$46.1M
Depreciation and amortization$45.8M$27.9M$17.8M$17.5M$17.5M
Stock-based compensation$38.6M$34.5M$22M$16.1M$6.75M
Change in working capital-$-3.1M-$-63.61M-$-23.39M-$-1.96M-$-33.64M
Accounts receivable-$-7.16M-$-11.1M-$-20.57M-$-33.97M-$-21.63M
Inventory$0.00$0.00$12.2M$27.6M-$-2.11M
Accounts payable-$-11.69M-$-30.43M-$-500K-$-2.52M$4.11M
Net cash provided by operating activities$114.6M$52.2M$68.2M$82.1M$70.3M
Investments in property, plant and equipment-$-10.11M-$-8.03M-$-28.53M-$-22.94M-$-19.22M
Acquisitions, net-$-548.6M-$-156.13M-$-7.54M-$-18.46M-$-3.9M
Net cash used for investing activities-$-539M-$-192.4M-$-65.52M-$-7.11M$16.5M
Common stock issued$0.00$0.00$0.00$0.00$40.1M
Common stock repurchased-$-15.43M-$-940K-$-10.19M-$-9.25M-$-5.74M
Dividends paid-$-7.88M-$-4.04M-$-62.07M-$-14.03M-$-31.09M
Net cash used for financing activities$569.4M$135.2M$3.42M-$-20.09M-$-47.75M
Net change in cash$144.9M-$-5.05M$6.12M$54.9M$39.1M
Cash at end of period$434.1M$289.1M$294.2M$288M$233.1M
Operating cash flow$114.6M$52.2M$68.2M$82.1M$70.3M
Capital expenditure-$-10.11M-$-8.03M-$-28.53M-$-22.94M-$-19.22M
Free cash flow$104.5M$44.2M$39.7M$59.2M$51.1M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Astrana Health, Inc.

        Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

        CEO
        Brandon K. Sim
        Employees
        3K
        Beta
        0.89

        Explore

        Frequently asked questions

        What is the intrinsic value of Astrana Health, Inc. (ASTH)?

        Astrana Health, Inc. (ASTH) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is ASTH undervalued?

        ASTH trades at a price of $28.90 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.